Vision &
Strategy
Our vision
Our vision is to build a leading portfolio of critical medicines that improves the standard of care for more patients around the world.
Our strategy
We capitalize on our leading position to further develop our Critical Care portfolio internationally while also leveraging existing portfolio and capabilities to scale up the Rare Diseases franchise.
We do this via our three growth strategies:
-
Commercial Excellence
Deliver development initiatives, increase penetration and maintain leadership
-
Smart R&D
Develop a unique pipeline of R&D projects focusing on high unmet medical needs
-
M&A Engine
Execute targeted and highly selective M&A
These are underpinned by our focus on sustaining operational excellence and strengthening the organisation.
Interested in joining us?
We’re always on the lookout for talented, passionate people who share our values and exhibit the behaviours that make working here different.